Print

FDA approves new treatment for metastatic triple-negative breast cancer

https://www.facingourrisk.org/XRAY/new-drug-approved-for-tnbc
Full article: https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-triple-negative-breast-cancer-has-spread-not-responded-other-treatments

The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies looking at new treatments for people with metastatic TNBC.  

A number of other clinical trials for treating patients with metastatic TNBC can be found here.

The following studies are looking at treatment for people with advanced solid tumors. 

 

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.